Detalhe da pesquisa
1.
Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington's disease.
Mol Ther
; 31(1): 282-299, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36116006